Title
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers
Document Type
Article
Publication Date
June 2020
Publication Title
bioRxiv
DOI
10.1101/2020.06.07.136366
Recommended Citation
Peng, David; Rodriguez, B.; Diao, Lixia; Gaudreau, Pierre; Padhye, Aparna; Ochieng, Joshua; Class, Caleb; Fradette, Jared; Gibson, Laura; Chen, Limo; Wang, Jing; Byers, Lauren; and Gibbons, Don, "Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers" (2020). Scholarship and Professional Work – COPHS. 282.
https://digitalcommons.butler.edu/cophs_papers/282
COinS